CODX vs LIN
Co-Diagnostics, Inc. Common Stock (CODX) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
CODX currently screens at market cap $31.4M. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the CODX and LIN stock pages for the full models.
Not investment advice.